Evaluation of the NEUROSWING Orthosis on Walking Speed in a Population With Dorsal and/or Plantar Flexor Deficits, With a View to a Reimbursement Application
Deficit of the dorsal and/or plantar flexors with at least one of the following components specific to the indication of an AFO:
* steppage
* foot drop,
* spasticity,
* failure to transfer weight-bearing,
* instability of weight-bearing phase
* compensatory hyperextension of the knee
* Muscular deficiency of the dorsal and/or plantar flexors principal or accessory
Ambulation possible with or without technical aids
First time using an orthosis used in the study
Being followed in one of the investigating centers whose management and rehabilitation in line with the study's visit schedule.
Having freely consented to participate
Affiliated with a social security scheme
You may not be if
Cognitive disorders, at the investigator's discretion, impacting the reliability of the clinical tests under study.
Pathology in progressive phase at the time of inclusion that could significantly impact walking (e.g. MS, ALS, etc.) during the entire study period.
Medically unstable (e.g. severe cardiovascular disorders) as judged by the investigating physician.
Behavioral disorders (opposition, agitation, dementia) which, according to the investigator's judgment, would have an impact on walking.
Already fitted with a carbon or NEUROSWING orthosis.
Height over 214cm
Weight over 193kg
Pregnant, parturient or breast-feeding women
Person deprived of liberty by a court order (including guardianship, curatorship and safeguard of justice) or administrative order
Person under psychiatric care or admitted to a health or social establishment for purposes other than research
Person in an emergency situation unable to give consent beforehand
Clareo Health | Evaluation of the NEUROSWING Orthosis on Walking Speed in a Population With Dorsal and/or Plantar Flexor Deficits, With a View to a Reimbursement Application
